Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting

BACKGROUND: Vaccination that prevents tuberculosis (TB) disease, particularly in adolescents, would have the greatest impact on the global TB epidemic. Safety, reactogenicity and immunogenicity of the vaccine candidate M72/AS01(E) was evaluated in healthy, HIV-negative adolescents in a TB endemic re...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Vaccine
Glavni autori: Penn-Nicholson, Adam, Geldenhuys, Hennie, Burny, Wivine, van der Most, Robbert, Day, Cheryl L., Jongert, Erik, Moris, Philippe, Hatherill, Mark, Ofori-Anyinam, Opokua, Hanekom, Willem
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845829/
https://ncbi.nlm.nih.gov/pubmed/26072017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.05.088
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items